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Purpose: The technical feasibility and potential benefits of voxel-based non-uniform dose 
prescriptions for biologically heterogeneous tumors have been widely demonstrated. In 
some cases, an “ideal” dose prescription has been generated by individualizing the dose 
to every voxel within the target, but often this voxel-based prescription has been 10 
discretized into a small number of compartments. The number of dose levels utilized, and 
the methods used for prescribing doses and assigning tumor voxels to different dose 
compartments have varied significantly. We present an investigation into the relationship 
between the complexity of the dose prescription and the tumor control probability (TCP) 
for a number of these methods.  15 
Methods: The linear quadratic model of cell killing was used in conjunction with a 
number of modelled tumors heterogeneous in clonogen density, oxygenation, or 
proliferation. Models based on simple mathematical functions, published biological data 
and biological image data were investigated. Target voxels were assigned to dose 
compartments using (i) simple rules based on the initial biological distribution; (ii) 20 
iterative methods designed to maximize the achievable TCP; or (iii) methods based on an 
“ideal” dose prescription.  
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Results: The relative performance of the simple rules was found to depend on the form of 
heterogeneity of the tumor, whilst the iterative and “ideal” dose methods performed 
comparably for all models investigated. In all cases the maximum achievable TCP was 25 
approached within the first few (typically 2-5) compartments.  
Conclusion: Results suggest that irrespective of the pattern of heterogeneity, the optimal 
dose prescription can be well approximated using only a few dose levels, but only if both 
the compartment boundaries and prescribed dose levels are well chosen.  
 30 
Key words: tumor control probability, radiation therapy, treatment planning, dose 
painting, functional imaging
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I. INTRODUCTION 
There has been much discussion in recent years of the use of deliberately non-uniform 
dose distributions in radiotherapy1-3, and both the technical feasibility and potential 35 
benefits of “dose-painting” have been widely demonstrated4-12. There are a number of 
possible approaches to the incorporation of radiobiological modelling into the treatment 
planning process. One such methodology is to use a model predicting tumor response to 
generate a non-uniform dose prescription to the target8. This prescription can then be 
used in conjunction with dose constraints for normal tissue (which can be dose-volume 40 
based or radiobiological and may take into account functional heterogeneity of organs at 
risk) to generate a clinical treatment plan. A schematic diagram of this methodology is 
presented in figure 1. An alternative is to use models predicting both tumor response and 
normal tissue damage to directly optimise a treatment plan using a metric such as the 
probability of uncomplicated tumor control, known as P+4,13. We have adopted the former 45 
methodology to enable us to consider the model predicting tumor response independent 
of that predicting normal tissue response. In this work we consider only the first stage of 
this process, the generation of a dose prescription (shown within the dashed box in figure 
1). With information on biological variations within a tumor, obtained using functional 
imaging, it is possible to individualize the dose prescription to each imaged voxel within 50 
the target8,12,14,15. However, more commonly the target has been divided into a small 
number of compartments such that the quasi-continuous optimal dose distribution is 
quantized into a few discrete dose levels5-7,9,16. The aim of this work is to investigate the 
relationship between the complexity of a treatment prescription, measured by the number 
of prescribed dose levels, and the quality of the plan, represented by the TCP.  55 
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 For an inhomogeneous tumor, the TCP can be increased with respect to a uniform 
dose distribution by redistributing dose without increasing the integral dose to the target. 
In general, under these conditions the TCP is expected to increase as the number of dose 
levels is increased. For any given target, the precise form of this relationship will depend 
on the heterogeneity of the tumor, the positioning of the boundaries between different 60 
compartments, and the choice of prescribed dose levels. The key practical questions are 
therefore: (i) how many dose levels are worthwhile; (ii) what is the optimal method for 
assigning voxels to different compartments; and (iii) how should we set the prescribed 
doses to those compartments? We have addressed these questions by investigating the 
behaviour of a number of model tumors with a variety of forms of biological 65 
heterogeneity.  
 
II. METHODS 
II.A. Radiobiological Modelling 
 If radiation response is described by the linear-quadratic model, the surviving 70 
fraction (SF) of tumor cells following irradiation to dose D in f fractions is given by: 
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where α and β are the linear and quadratic parameters of cell kill, T is the overall treatment time 
and γ  the repopulation rate, with repopulation beginning Tk days after the start of treatment. The 
tumor control probability (TCP) is found by assuming Poisson statistics and calculating the 75 
probability of there being no viable tumor cells remaining. Considering a tumor divided into N 
equal-sized voxels each of volume v, the probability of killing all tumor cells within a single 
voxel i is given by:  
C P South et al 
 5
( )
















−+







−−⋅−= ki
ii
iiii TTf
DDvTCP γβαρ
2
expexp     (2) 
where ρi is the clonogenic cell density in voxel i and Di the dose delivered to voxel i. Note that 80 
the radiosensitivity parameters are also allowed to vary spatially to account for local variations in 
oxygenation17,18. The overall TCP for the whole tumor is then the product of the TCPs for all 
voxels2: 
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The local values of the linear and quadratic terms of radiosensitivity are given by intrinsic 85 
radiosensitivity terms α and β multiplied by factors Ai and Bi respectively, such that 
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where Ai and Bi are functions of the local oxygenation. The oxygen dependence takes the form 
proposed by Wouters and Brown19: 
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where pi is the partial pressure of oxygen in voxel i, 
maxα
OER  and 
maxβOER are maximum oxygen 
enhancement ratios for α and β respectively, and Km is the oxygen partial pressure at which half-
maximum sensitization occurs. 
 For simplicity, we assume an idealized situation where we can precisely deliver 
any desired dose distribution, with the resolution of the biological imaging voxels. For 95 
the purposes of this analysis, we can then simply consider a tumor as a series of N voxels 
with differing biological properties and dose prescriptions. We also assume knowledge of 
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the intrinsic radiosensitivity parameters α and β for the individual tumor15, enabling us to 
use single values of α and β rather than a population distribution. However, we 
subsequently consider the impact of variations in these parameters.  100 
II.B. Dose Optimization 
 In order to allow a fair quantitative comparison between plans of differing 
complexity, we used a method which maximizes the TCP by redistributing dose between 
compartments, subject to a fixed integral dose8,16,20. This method has been previously 
described by the authors15.  105 
II.C. Tumor Models 
 The key biological parameters affecting the TCP in a given voxel are the clonogen 
density, the oxygenation and the proliferation rate. We have investigated the behavior of 
simple model tumors in which either clonogen density, oxygenation or proliferation is 
allowed to vary across the tumor, with that variation taking the form of four different 110 
simple mathematical functions. We also present data for models in which variations in 
oxygenation are based on published oxygen partial pressure histograms for a number of 
tumor types. Finally, we constructed tumor models from a number of clinical 18F-
fluorodeoxyglucose (FDG) PET data sets. Whilst it would be inappropriate to use FDG 
uptake as a surrogate for clonogen density, hypoxia or proliferation, it is believed to be 115 
influenced by all these factors21-26. We have therefore used FDG-PET data from 3 lung 
tumors, not to demonstrate a clinical application, but merely to indicate typical patterns of 
biological heterogeneity. For each scan we created models taking the PET data to 
represent variations in clonogen density, oxygenation, or a combination in order to 
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investigate whether the predictions for these models fell within the range of the 120 
mathematical models presented.  
 We have chosen radiobiological parameters from the literature to represent a 
typical lung tumor: α = 0.35 Gy-1; α/β = 10 Gy; γ = 0.231 day-1 (equivalent to a potential 
doubling time of 3 days); Tk = 28 days27; 
maxα
OER = 2.5 ; 
maxβOER =3.0; and Km =3.28 
mmHg19. TCPs are calculated for treatments which deliver an integral dose equivalent to 125 
a uniform irradiation of 64 Gy in 32 fractions, delivered over 44 days (i.e. treated 5 days 
per week).  
II.C.1. Simple Models 
 The simple mathematical models each contain 1000 voxels, across which 
clonogen density, oxygenation or proliferation varies as a linear, exponential, sigmoidal 130 
or logarithmic function of voxel number. For models with heterogeneous clonogen 
density the oxygen pressure has been set to a uniform 100 mmHg. To aid comparison the 
tumors have been normalized so that they all have a minimum density of 105 clonogens 
per voxel (which is approximately the lower detection limit using current PET 
techniques21), and all contain a total of 109 clonogens28. This means that a uniform dose 135 
gives the same total TCP for each model.  
 For models with heterogeneous oxygenation, the partial pressure of oxygen is 
allowed to vary linearly, exponentially, sigmoidally and logarithmically between 1 and 
100 mmHg. Additional models are derived by linearly interpolating published oxygen 
partial pressure histograms for squamous cell carcinomas, breast cancers and gastric 140 
adenocarcinoma29. For these hypoxic models, the total number of clonogens has been 
chosen such that: (i) a uniform irradiation to 64 Gy results in the same TCP for each 
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model; (ii) the maximum achievable TCP is significantly greater than 0; and (iii) 
clonogen densities fall within a clinically realistic range for all models. When the 
uniform-dose TCP is 0.001, the total clonogen number ranges from 1.03×105 for the 145 
sigmoidal model to 1.95×106 for the logarithmic model, and the maximum achievable 
TCP is greater than 0.9 in each case.  
 For models with a heterogeneous proliferation rate, γ has been allowed to vary by 
a factor of 100 from a maximum value of 0.231 day-1, with variations taking linear, 
exponential, sigmoidal and logarithmic forms. The partial pressure of oxygen is set to a 150 
uniform 100 mmHg and again the total number of clonogens is normalized such that 
uniform irradiation results in the same TCP for each model. Figure 2 shows the variation 
in clonogen density, oxygenation or proliferation rate for each of these models.   
II.C.2. PET-Based Models 
 The PET-based models were created by extracting a cuboid of data from a clinical 155 
18F-FDG PET scan, centred on a lung tumor. Background voxels were removed using a 
threshold of 15% of the peak voxel value, and the remaining voxels sorted into order of 
intensity. For all models, this threshold was within +/- 0.5 of the absolute SUV threshold 
of 2.5 proposed by Paulino and Johnstone for the segmentation of tumors30 and we 
determined that our results were insensitive to variations in this threshold (data not 160 
presented). We consider models in which variations in voxel intensity are taken to reflect 
variations in either clonogen number or hypoxia, or both. 
 For models with heterogeneous clonogen density, image intensities were 
converted into clonogen numbers assuming a linear relationship between FDG uptake and 
clonogen density21,22 and normalizing to give a minimum clonogen density of 105 per 165 
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voxel and a total clonogen number of 109 as before. The total number of tumor voxels 
varies between 237 and 2864 for these models. For models with heterogeneous 
oxygenation we have assumed that FDG uptake is negatively correlated with 
oxygenation23-25. Oxygen partial pressures have been allowed to vary within a range of 1 
to 100 mmHg and we have again chosen a clonogen density for each model which results 170 
in a TCP of 0.001 for a uniform irradiation to 64 Gy. This combination of parameters 
again allows a significant TCP to be achieved by redistributing dose whilst keeping all 
parameters within a clinically realistic range. Finally, for models in which both clonogen 
density and oxygenation are allowed to vary, the clonogen distribution from the first PET 
model is combined with the oxygen distribution from the second for each tumor. It should 175 
be noted that these models imply that hypoxia is inversely related to clonogen density, 
which is unlikely to be clinically realistic as it suggests that hypoxic cells are more viable 
than normoxic cells. However, they are included in order to present a worst-case scenario 
in which variations in clonogen density and oxygenation interact constructively, as this is 
the situation in which the greatest dose heterogeneity will be required. Figure 3 shows 180 
PET images taken through the centre of each tumor and the derived clonogen and oxygen 
distributions for each of the PET models.  
II.D. Setting Compartment Boundaries 
II.D.1. Heterogeneous Clonogen Density 
 In general a non-uniform dose distribution is designed by allocating tumor voxels 185 
to a number of compartments, then optimizing the prescribed doses to those 
compartments. For models in which only clonogen density varies between voxels, the 
optimal dose distribution can be directly calculated for any number of compartments, as 
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described above15. We investigated a number of methods for allocating voxels to different 
compartments. These methods fall into three categories: simple rules based on the 190 
clonogen density distribution; numerical optimizations in which the boundary positions 
are iteratively adjusted to maximize the total TCP; and methods in which the optimal 
dose distribution is calculated with an individualized dose to every voxel, and 
compartments are designed based on this ideal dose distribution.  
II.D.1.a. Simple Methods 195 
Equal volumes (Vol): the boundaries are set such that each compartment contains the 
same number of voxels.  
Equal clonogens (Clons): the boundaries are set such that each compartment contains 
the same total number of clonogens.  
Evenly spaced clonogen density thresholds (Thresh): compartments have evenly-200 
spaced boundaries between the pre-determined maximum and minimum clonogen density 
limits.  
II.D.1.b. Iterative Methods 
Exhaustive search (Exh): the dose distribution is optimized to give the maximum 
achievable TCP for every possible combination of boundary positions, and the set of 205 
positions resulting in the highest TCP is chosen.  
Gradient ascent (Grad): boundary positions are iteratively optimized using a gradient 
ascent method to find the maximum overall TCP.  
II.D.1.c. Ideal Dose Distribution Methods 
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Evenly spaced dose levels (Dose): initial compartment doses are set by averaging over 210 
the ideal dose distribution within each compartment, with boundaries chosen to give 
approximately evenly-spaced dose levels.  
Optimum mean square quantizer (OMQ): this method calculates the compartment 
boundaries and dose levels which result in a dose profile which is the best fit to the ideal 
dose distribution. This is analogous to the problem of designing multiple static fields to 215 
give the best fit to an optimal fluence profile31,32. Details are given in the appendix.  
 In each case, once the boundaries have been set using one of these methods, the 
dose-levels are re-optimized to ensure that the maximum possible TCP is achieved for 
each configuration.  
II.D.2. Heterogeneous Oxygenation or Proliferation Rate 220 
 For tumors with heterogeneous oxygenation (with or without clonogen density 
variations), for small numbers of compartments the dose distribution was optimized by 
iteratively adjusting the boundary positions to maximize TCP. For each set of boundary 
positions, compartment dose is given by the average voxel dose delivered to a 
compartment by the ideal dose distribution. Where the number of compartments was 7 or 225 
greater, it was found that setting compartment boundaries using the even dose levels 
approach gave TCPs within 0.5% of this iterative method in all cases. This method was 
therefore adopted for larger numbers of compartments as it reduced calculation times and 
eliminated the risk of being influenced by local minima. A similar approach was taken to 
optimizing dose distributions for models with heterogeneous proliferation rates.  230 
II.D.3. Sensitivity to Variations in Chosen Parameter Values 
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 The calculated TCP values for all these models will be sensitive to variations in 
the precise value of each of the fixed parameters chosen for that model. In order to 
determine whether conclusions drawn from the behavior of these models are robust 
against such variations, we also repeated our analysis for a subset of the models with 235 
previously fixed values allowed to vary. We would expect our results to be particularly 
sensitive to our choice of oxygen pressures. We present results for the following: the 
sigmoidal clonogen density model, with the uniform oxygenation allowed to vary; the 
sigmoidal oxygenation model, with the minimum partial pressure of oxygen allowed to 
vary; the model based on the gastric adenocarcinoma oxygen histogram, with the 240 
radiosensitivity allowed to vary.  
III. RESULTS 
III.A. Simple Models 
III.A.1. Heterogeneous Clonogen Density 
 Figure 4a shows an exhaustive search of boundary positions for the 2-245 
compartment case for each of the simple mathematical tumor models, with the dose-
levels optimized to give the maximum achievable TCP for each boundary position. This 
illustrates the importance of dividing the tumor in such a way as to enable the maximum 
possible benefit from a non-uniform dose distribution. It also shows that the potential 
benefits of redistributing dose depend on the heterogeneity of the tumor – the 250 
improvements in TCP are much greater for tumors with exponential and sigmoidal 
variations in clonogen density than for the largely homogeneous logarithmic model. Of 
course in the extreme case of a uniform tumor, no improvement in TCP would be 
possible, since a uniform distribution is optimal in this case33.  
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 Figure 4b and c show the relationship between complexity and TCP for the equal 255 
volumes, equal clonogens, even clonogen density thresholds and even dose levels 
methods, for the exponential and sigmoidal tumor models. It is clear that the relative 
performance of the simple methods depends on the form of tumor heterogeneity. The 
even dose levels approach works consistently well compared with the other simple 
methods when there is significant inhomogeneity across the tumor.  260 
 Figure 4d shows again the even dose levels approach along with the iterative 
methods (exhaustive search and gradient ascent) and the OMQ for the same 4 tumor 
models. Again we see that the potential benefits of dose redistribution depend on the 
heterogeneity of the tumor, but also that for all these models, most of the benefit occurs 
within the first few compartments. In all cases greater than 99.5% of the maximum 265 
achievable TCP is reached within 4 compartments. The exhaustive search was only 
carried out for up to 3 compartments since beyond this it becomes extremely 
computationally intensive. All these methods generally achieve similar results, suggesting 
that the gradient ascent method is not significantly hampered by local maxima for these 
models, although this may not be true for all cases (indeed this method gives slightly sub-270 
optimal results for the sigmoidal model in the 4 to 7 compartment range). The OMQ 
approach has the advantage that it is an analytical method, it is relatively fast and it 
appears stable provided the number of compartments is small compared to the number of 
voxels.  
III.A.2. Heterogeneous Oxygenation or Proliferation Rate 275 
 Figure 5 (a) and (b) show the relationship between TCP and number of dose 
levels for the mathematically derived and clinically derived hypoxic models respectively. 
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Figure 5 (c) shows results for the mathematical models with varying proliferation rate. 
Once again the majority of the benefit occurs within the first few compartments for all 
these models.  280 
III.A.3. Sensitivity to Variations in Chosen Parameter Values 
 Figure 6 shows the complexity versus TCP curve for a number of the models 
previously presented, with a key fixed parameter allowed to vary in each case. In figure 6 
(a), the analysis for the sigmoidal clonogen density model is repeated with the uniform 
partial pressure of oxygen varying between 20 and 100 mmHg. Figure 6 (b) shows results 285 
for the sigmoidal oxygenation model, with the minimum partial pressure of oxygen 
varying between 0 and 10 mmHg. The total clonogen number was fixed equal to that 
used for the original model. Figure 6 (c) shows the effect of varying the radiosensitivity 
parameters on the behaviour of the hypoxic model based on the gastric adenocarcinoma 
oxygen histogram. In this case α was varied between 0.15 and 0.5 Gy-1 with the α/β ratio 290 
fixed at 10 and the uniform clonogen density scaled to give the same TCP in each case 
for a uniform dose of 64Gy. In each case investigated, whilst a change of parameter 
values affected the absolute TCP values and the initial slope of the curve, the overall 
shape of the curve was largely unaffected.  
III.B. PET-Based Models 295 
Comparing the distributions of uptake in figure 3 with the simple models in figure 2, we 
would expect the results for the PET model tumors to fall within the range of the results 
for the mathematical models investigated. Figure 7 shows results of the gradient ascent 
method for each of the PET models. The resulting dose prescription maps are also shown 
for 1 to 5 compartments, and for the optimal dose distribution in each case. Note that 300 
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these maps represent a single slice through each tumor, and that although the most 
heterogeneous slice of each model has been chosen, in some cases not all the available 
dose levels are present on the slice displayed. It is clear that where both clonogen density 
and oxygenation vary across the tumor, hypoxia is the dominant effect in determining the 
most effective dose distribution. Again, the majority of the benefit is attained within the 305 
first few compartments for all the models investigated.  
 
IV. DISCUSSION 
 The results presented above suggest that, for a wide range of heterogeneous 
biological distributions, the vast majority of the benefit of dose redistribution can be 310 
attained using very few dose levels. However, this is only true if both the prescribed dose 
levels and the dividing lines between compartments are well chosen. Due to the 
uncertainties inherent in interpreting biological image data, previous work demonstrating 
the feasibility of dose-painting has tended to link the biological image intensities and 
subsequent dose prescription levels somewhat arbitrarily, often quantizing either 315 
biological parameters or dose into very few levels5-9,16. For example, Yang and Xing9 
present an elegant method for optimizing a non-uniform dose prescription on the voxel 
scale, but demonstrate it using models in which the biological variations are quantized 
into a few discrete levels. Das et al7 consider continuously varying biological 
distributions and dose prescriptions but generate their prescription by setting dose 320 
proportional to PET voxel intensity. Sovik et al11 used very similar radiobiological 
models to those presented here to investigate the impact of varying the number of dose 
levels on the benefit of redistributing dose for 4 hypoxic tumor models. We have 
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expanded upon this work to investigate a wide range of theoretically and clinically 
derived biological distributions to determine whether their conclusions are generally 325 
applicable. Taking into account variations in clonogen density, oxygenation and 
proliferation rate, our results are consistent with their observation that increasing the 
number of dose levels beyond 4 yields little additional benefit. We have however 
demonstrated a number of methods to approximate the optimal dose prescription for any 
number of discrete dose levels for a given non-uniform tumor.  330 
 We have made the simplifying assumption that any desired dose distribution can 
be accurately delivered. Whilst this is clearly not a realistic expectation, beam-shaping 
devices with a resolution comparable to that of most functional images are now widely 
available. For example, multi-leaf collimators with an effective leaf width of 3 to 5mm 
are not uncommon, giving the capability to produce fluence modulations at the same 335 
scale as a typical PET voxel. Whilst the steepest achievable dose gradients will be 
fundamentally limited by the penumbra of the beam-shaping device, and small-field 
dosimetry remains problematic, we would nevertheless expect to be able to deliver a 
close approximation to the desired dose distribution in the majority of cases34. The major 
limiting factors for dose-painting therefore remain the quantification of biological 340 
parameters from functional imaging and the validation of models predicting tissue 
response35.  
 It should be noted that our observations relate to a prescribed target dose 
distribution, not to a final planned clinical dose. In the absence of normal tissue dose 
constraints, we would expect these two distributions to be closely matched, as discussed 345 
above. However, where organs at risk are present close to or overlapping with the target, 
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a reduction in the target dose may be necessary in these regions. This could of course lead 
to an increase in the number of dose levels present in the final planned target dose 
distribution.  
 The resolution of the dose prescription is limited by the PET resolution and/or the 350 
resolution with which we can physically modulate dose, whichever is coarser. Biological 
heterogeneities are likely to exist on a much finer scale than we can hope to either image 
non-invasively or modulate external-beam dose. Acquiring biological information on a 
finer scale than the dose prescription voxel size would result in the dose to each 
prescription voxel being largely determined by the least radiosensitive region within that 355 
voxel. This means that our current approach, in which we take each PET voxel value to 
be representative of all cells within that PET voxel, is likely to underestimate both the 
heterogeneity of the optimal dose distribution and the potential benefit of dose 
redistribution36. However, we have demonstrated that a wide range of optimal dose 
distributions, optimized making a variety of assumptions, can be well approximated using 360 
very few dose levels and a small increase in the dose range of the optimal dose 
distribution is unlikely to affect this conclusion.  
 It is clear that where significant hypoxia exists, this will dominate the dose 
prescription, and the increase in TCP achieved by dose redistribution is modest for the 
models in which only clonogen density or proliferation vary. However, even an increase 365 
of 5% in TCP could be considered clinically important, particularly if it can be achieved 
with only a modest increase in the complexity of the plan. In the case of common cancers 
such as lung or prostate, even a small improvement in TCP could result in an improved 
outcome for a large number of patients.  
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 The initial steepness of the TCP versus complexity curve for all significantly 370 
inhomogeneous tumors indicates that a relatively simple dose prescription consisting of 2 
to 5 dose levels will be sufficient to produce a dose distribution that is very close to 
optimal. This will simplify the task of designing treatment planning systems capable of 
fully utilizing biological information from functional imaging to optimize planned dose 
distributions. Plotting this curve for individual tumors, taking into account variations in 375 
clonogen density, oxygenation and proliferation, could assist in choosing the number of 
dose levels to use in each specific case. This would also enable the identification of cases 
for which the overall benefit of dose redistribution is minimal and a simple uniform 
irradiation would be the most appropriate treatment. We have demonstrated a number of 
methods for assigning dose levels which could easily be implemented within a treatment 380 
planning system. The even dose levels method, the OMQ and the iterative approaches all 
appear to give comparable results, so the most appropriate method will depend on the 
relative importance of robustness and computational efficiency. The optimal approach is 
likely to be one in which, for small numbers of dose levels, the boundaries are iteratively 
optimized, whilst the even dose levels approach is used where larger numbers of dose 385 
levels are required and iterative optimization becomes computationally prohibitive.  
 
V. CONCLUSIONS 
 When designing non-uniform dose prescriptions for biologically heterogeneous 
tumors, only a few dose levels are required, provided these dose levels are well chosen. 390 
The quantification of biological parameters from functional imaging remains the limiting 
factor in the clinical implementation of dose painting.  
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APPENDIX: OPTIMUM MEAN SQUARE QUANTIZER METHOD 
 A quantizer maps a continuous variable x onto a discrete variable 'x , which takes 400 
values from a finite set of numbers. For a quantizer with L levels, this mapping is 
achieved by defining a set of “transition levels” {t1,…,tL+1} and assigning “reconstruction 
levels” {r1,….,rL} such that if tk<x<tk+1, then krx =' . The optimum mean square quantizer 
sets both transition and reconstruction levels so as to minimize the mean square error 
from the original distribution for a given number of quantization levels31. Let x be 405 
prescribed voxel dose, with a continuous probability density function px(x) determined 
from the ideal dose distribution. The mean square error is then:  
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The error can be minimized by differentiating with respect to both tk and rk and setting 
the results to zero:  410 
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This leads to the following: 
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If we set t1 and tL+1 equal to the minimum and maximum voxel doses from the ideal 
distribution, equations A4 and A5 can be solved using an iterative method to give both 
transition levels and prescribed dose levels.  
 
420 
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FIG. 1. Schematic diagram of the proposed methodology for biologically conformal treatment 
planning. The aspects of the process considered in this work are contained within the dashed box.  
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FIG. 2. (a) Clonogen distributions for the simple mathematical models (linear, exponential, 
sigmoid and logarithmic); (b) Oxygen distributions for the simple mathematical models; (c) 
Oxygen distribution for the models based on published oxygen partial pressure histograms: 
squamous cell carcinoma(SCC), breast cancer(BC) and gastric adenocarcinoma(GAC); (d) 
Proliferation rates for the simple mathematical models.    430 
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FIG. 3. Assumed clonogen (solid lines) and oxygen (dashed lines) distributions for tumor models 
based on 3 clinical 18FDG-PET scans. For each scan, models are presented for which PET voxel 
intensity represents: (a) clonogen density; (b) hypoxia and (c) both. Color scales indicate the 
initial PET voxel standardized uptake values (SUVs).  440 
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FIG. 4. (a)The maximum achievable TCP as a function of boundary position for the 2-
compartment case for each of the simple models with heterogeneous clonogen density (linear, 
exponential, sigmoid and logarithmic); (b) TCP as a function of complexity for the model with 445 
exponentially varying clonogen density using the equal volume, equal clonogens, evenly-spaced 
clonogen density threshold and evenly-spaced dose-level methods; (c) TCP as a function of 
complexity for the model with sigmoidally varying clonogen density using the equal volume, 
equal clonogens, evenly-spaced clonogen density threshold and evenly-spaced dose-level 
methods ; (d) TCP as a function of complexity for the even dose levels(Dose), gradient 450 
ascent(Grad), optimum mean square quantizer(OMQ) and exhaustive search(Exh) methods for 
the simple models with heterogeneous clonogen density (linear, exponential, sigmoid and 
logarithmic). 
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FIG. 5. (a)TCP as a function of complexity for the simple mathematical models with 
heterogeneous oxygenation (linear, exponential, sigmoid and logarithmic); (b) TCP as a function 460 
of complexity for the simple models based on published oxygen partial pressure histograms: 
squamous cell carcinoma(SCC), breast cancer(BC) and gastric adenocarcinoma(GAC); (c) TCP 
as a function of complexity for the simple mathematical models with heterogeneous proliferation 
rate (linear, exponential, sigmoid and logarithmic).   
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FIG. 6. (a) TCP versus complexity for the sigmoidal clonogen density model with the uniform 
partial pressure of oxygen varying between 20 and 100 mmHg; (b) TCP versus complexity for the 
sigmoidal oxygenation model with the minimum partial pressure of oxygen varying between 0 470 
and 10 mmHg; (c) TCP versus complexity for the model based on the gastric adenocarcinoma 
oxygen histogram with the radiosensivity α varying between 0.15 and 0.5 Gy-1.  
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FIG. 7. TCP as a function of complexity for each of the PET-based models. The resulting dose 
prescription maps are also shown for 1 to 5 compartments, and for the optimal dose distribution 
for the cases in which PET uptake represents: (a) clonogen density; (b) hypoxia and (c) both.  
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